Dr Reddys Laboratories Share Price Today - Live Blog for November 11, 2025

Dr Reddys Laboratories Ltd's stock has surged by 0.17%, and it is currently trading at ₹1,213.35. Additionally, the stock maintains a PE ratio of 17.5300, while the industry PE is 33.4157.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.07% gain, with the share price now at ₹1,212.05. Notably, the stock's PE ratio stands at 17.5300, and its Return on Equity (ROE) is 16.0277%.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.07%, reaching a current market price of ₹1,211.15. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Dr Reddys Laboratories Ltd is facing a -0.12% decline and is currently trading at ₹1,211.95 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd experienced a -0.08% slump and is currently trading at ₹1,213.35. While the stock maintains a PE ratio of 17.5300, the industry PE is 33.4157, raising questions about valuation.

Dr Reddys Laboratories Ltd's shares experienced a 0.09% uptick, and they are currently valued at ₹1,214.30, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

After a notable 0.03% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,213.30. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

Dr Reddys Laboratories Ltd's share price rallied by 0.14%, reaching the current market price of ₹1,213.55. This surge is indicative of the stock's recent positive performance.

The share price of Dr Reddys Laboratories Ltd plunged by -0.15%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,210.55, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd observed a remarkable 0.06% surge in its share price and is presently trading at ₹1,213.00. The increased investor interest is driving this surge.

With a remarkable 0.11% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,212.65. Notably, this stock has a Price-to-Earnings (PE) ratio of 17.5300, while the industry's PE ratio is 33.4157.

With a -0.16% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,212.00. Investors should examine the factors driving this decline. The stock's PE ratio is 17.5300, whereas the industry PE ratio stands at 33.4157.

Dr Reddys Laboratories Ltd's share price rallied by 0.25%, reaching the current market price of ₹1,214.00. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd witnessed a substantial 0.07% increase in its share price and is currently trading at ₹1,210.00. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd's share price rallied by 0.16%, reaching the current market price of ₹1,209.60. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.04%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,207.65, and market participants are assessing the implications. The stock has a PE ratio of 17.5300, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.18%, reaching a current market price of ₹1,205.75. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

With a -0.09% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,206.95. Investors should examine the factors driving this decline. The stock's PE ratio is 17.5300, whereas the industry PE ratio stands at 33.4157.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.20%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,206.00 per share.

With a remarkable 0.20% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,206.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 17.5300, while the industry's PE ratio is 33.4157.

After a significant 0.20% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,206.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.20% upswing, and it's currently trading at ₹1,206.00 per share. Investors are closely watching this development.

After a significant 0.20% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,206.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd witnessed a -0.04% decrease in its share price, and it is currently trading at ₹1,202.15. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.5300, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd is facing a -0.04% decline and is currently trading at ₹1,202.15 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.04% drop, and it's now trading at ₹1,202.15 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

After a -0.39% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,202.30. The stock has a PE ratio of 17.5300, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd observed a remarkable 0.17% surge in its share price and is presently trading at ₹1,206.00. The increased investor interest is driving this surge.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.01% in its share price, and it currently trades at ₹1,202.85 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Demonstrating a commendable 0.24% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,201.90. In terms of valuation, the stock maintains a PE ratio of 17.5300, while the industry PE ratio stands at 33.4157.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.67%, signalling a challenging period. Currently trading at ₹1,199.90, this stock has caught the eye of bargain hunters, who may be considering their entry points.